BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs2476601
,
ZBTB7A
,
cell-cell adhesion
,
Ischemia
,
Heart
,
Autoimmunity
,
Rosiglitazone
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
neratinib
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
TNFAIP3
CRIP1
HOXC6
CPVL
AGR2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
organic cyclic compound binding
regulation of nitrogen compound metabolic process
heterocyclic compound binding
cytosol
PUJANA_BRCA1_PCC_NETWORK
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Bladder cancer and ovarian cancer parental or neratinib-resistant cells treated with neratinib
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
Multiple cancer cell lines treated with 32 kinase inhibitors
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Neratinib as adjuvant therapy in patients with HER2 positive breast cancer: expert opinion.
Hybrid solid-phase extraction to overcome interference due to phospholipids for determination of ner…
Cellular responses after (neratinib plus pemetrexed) exposure in NSCLC cells.
Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers.
Development of a Validated Bioanalytical UPLC-MS/MS Method for Quantification of Neratinib: A Recent…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Fulvestrant + Neratinib In Breast Cancer
Real-life Pan-HER-blockade With Neratinib
Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy Subjects
A Study Of Neratinib (HKI-272) And Capecitabine In Japanese With Solid Tumor
Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ